Prophylactic drug treatment of migraine;Traitement médicamenteux de fond de la migraine

Revue Neurologique

Volumn 161, Issue 6-7, 2005, Pages 681-684

  Massiou, H ^a   Bousser, M G ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Directions for use; Migraine; Prophylactic drug treatments

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANGIOTENSIN II ANTAGONIST; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; INDORAMIN; METHYSERGIDE; METOPROLOL; NADOLOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXETORONE; PIZOTIFEN; PROPRANOLOL; TIMOLOL; TOPIRAMATE; VALPROIC ACID;

ALOPECIA; ASTHENIA; CLINICAL TRIAL; CONCENTRATION LOSS; CONFERENCE PAPER; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG WITHDRAWAL; ERGOTISM; EXTRAPYRAMIDAL SYNDROME; GLAUCOMA; HUMAN; IMPOTENCE; INSOMNIA; MIGRAINE; MORBIDITY; MYOPIA; NAUSEA; NEPHROLITHIASIS; NIGHTMARE; PARESTHESIA; PROPHYLAXIS; SOMNOLENCE; ULCER; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 21644462632     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85116-1     Document Type: Conference Paper

References (11)

1. BRANDES JL, SAPER JR, DIAMOND M et al. (2004). Topiramate for migraine prevention: a randomized controlled trial. JAMA, 291: 965-973.
2. DIENER HC, TFELT-HANSEN P, DAHLOF C et al. (2004). Topiramate in migraine prophylaxis - Results from a placebo-controlled trial with propranolol as active control. J Neurol, 251: 943-950.
3. DOOSE DR, WANG SS, PADMANABHAN M, SCHWABE S, JACOBS D, BIALER M. (2003). Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia, 44: 540-549.
4. GOADSBY PJ. (1997). How do the currently used prophylactic agents work in migraine? Cephalalgia, 17: 85-92.
5. INTERNATIONAL HEADACHE SOCIETY CLINICAL TRIALS SUBCOMMITTEE. (2000). Guidelines for controlled trials in migraine: second edition. Cephalalgia, 20: 765-786.
6. MASSIOU H. (2000). Les traitements prophylactiques de la migraine. Rev Neurol (Paris), 156: 4S79-4S86.
7. SCHRADER H, STOVNER LJ, HELDE G, SAND T, BOVIM G. (2001). Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ, 322: 19-22.
8. SILBERSTEIN SD. (2000). Practise parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55: 754-762.
9. SILBERSTEIN SD, NETO W, SCHMITT J, JACOBS D, FOR THE MIGR-001 STUDY GROUP. (2004). Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol, 61: 490-495.
10. STEINER TJ, CATARCI T, HERING R, WHITMARSH T, COUTURIER EGM. (1994). If migraine prophylaxis does not work, think about compliance. Cephalalgia, 14: 463-464.
11. TRONVIK E, STOVNER LJ, HELDE G, SAND T, BOVIM G. (2003). Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA, 89: 65-69.